Novo Nordisk A/S (NYSE:NVO) Receives $53.33 Consensus PT from Analysts
Novo Nordisk A/S (NYSE:NVO – Get Free Report) has been assigned an average rating of “Hold” from the twenty-two brokerages that are presently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating, six have given a buy rating and one […]
27 Dec 07:32 · The Markets Daily